Related Experiment Video
Updated: May 19, 2026
09:20
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Recent developments in the management of heart failure
1Imperial College London (Roya Brompton Hospital), London, UK.
The Practitioner
|August 25, 2012
Summary
Diagnosing heart failure in primary care involves assessing symptoms like breathlessness and swelling, with B-type natriuretic peptide (BNP) blood tests being key. Further specialist assessment and echocardiography are crucial if BNP is elevated or a history of myocardial infarction exists.
Area of Science:
- Cardiology
- Primary Care Medicine
Background:
- Heart failure often presents insidiously in primary care with symptoms like exertional breathlessness, ankle swelling, orthopnoea, or paroxysmal nocturnal dyspnoea.
- Differential diagnoses are common, and not all patients exhibit the classic symptom constellation.
Purpose of the Study:
- To outline the diagnostic approach to suspected heart failure in primary care.
- To emphasize the role of B-type natriuretic peptide (BNP) testing and subsequent investigations.
- To highlight current treatment guidelines including lifestyle modifications and pharmacotherapy.
Main Methods:
- Clinical assessment of symptoms suggestive of heart failure.
- Utilizing B-type natriuretic peptide (BNP) levels as a key diagnostic biomarker.
- Further investigation with electrocardiogram (ECG), echocardiography, and specialist assessment when indicated.
- Review of current NICE and ESC guidelines for management.
Main Results:
- A normal BNP level makes heart failure unlikely, prompting consideration of alternative diagnoses.
- Elevated BNP or a history of myocardial infarction necessitates further cardiac assessment, including echocardiography.
- ECG findings can help rule out heart failure if completely normal.
- Lifestyle management and guideline-directed medical therapy (ACE inhibitors/ARBs, beta-blockers, diuretics, aldosterone antagonists) form the cornerstone of treatment.
Conclusions:
- Early and accurate diagnosis of heart failure in primary care is essential for timely management.
- BNP testing is a critical tool for ruling out heart failure.
- Optimizing pharmacotherapy, including potential addition of ivabradine for specific heart rate criteria, is vital for symptomatic patients.
Related Concept Videos
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...